[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review

June 2021 | 102 pages | ID: J5586235190EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Johnson & Johnson (J&J) researches, develops, manufactures, and sells pharmaceutical products, medical devices and consumer products. The company provides pharmaceuticals for immune diseases, cancer, neurological disorders, infectious, cardiovascular and metabolic diseases; consumer products in oral care, baby care, beauty, over-the-counter (OTC) pharmaceutical, women’s health and wound care categories; and medical devices for use in the cardiovascular, orthopaedic, general surgery and vision care fields. J&J distributes pharmaceutical and medical products to retailers, wholesalers, health care professionals and hospitals; and offers consumer products through retail outlets and distributors. The company offers its products in the US; Europe; Asia-Pacific and Africa; and Western Hemisphere (excluding the US). J&J is headquartered in New Brunswick, New Jersey, the US.

Johnson & Johnson Key Recent Developments

Jun 11,2021: Johnson & Johnson announces six global winners for the 2021 women in STEM2D Scholar Awards
Jun 09,2021: Johnson & Johnson releases 2020 health for humanity report highlighting performance and progress on Environmental, Social and Governance priorities
May 20,2021: Johnson & Johnson Medical Korea and Johnson & Johnson Innovation announce launch of Seoul Innovation QuickFire Challenge on smart surgery in collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute
May 11,2021: Kadant Johnson Promotes Jim Maggard to Lead Paper, Packaging and Tissue Sales
Apr 23,2021: Collaboration with Johnson & Johnson Innovation to jump-start search for new malaria drugs

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Johnson & Johnson - Key Facts
Johnson & Johnson - Key Employees
Johnson & Johnson - Key Employee Biographies
Johnson & Johnson - Major Products and Services
Johnson & Johnson - History
Johnson & Johnson - Company Statement
Johnson & Johnson - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Johnson & Johnson - Business Description
Business Segment: Consumer
Overview
Performance
Key Stats
Business Segment: Medical Devices
Overview
Performance
Key Stats
Business Segment: Pharmaceutical
Overview
Performance
Key Stats
Geographical Segment: Asia-Pacific, Africa
Performance
Geographical Segment: Europe
Performance
Geographical Segment: The US
Performance
Geographical Segment: Western Hemisphere excluding U.S.
Performance
R&D Overview
Johnson & Johnson - Corporate Strategy
Johnson & Johnson - SWOT Analysis
SWOT Analysis - Overview
Johnson & Johnson - Strengths
Johnson & Johnson - Weaknesses
Johnson & Johnson - Opportunities
Johnson & Johnson - Threats
Johnson & Johnson - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES, POWER FINANCIAL DEALS AND ALLIANCES

Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Johnson & Johnson, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jun 11, 2021: Johnson & Johnson announces six global winners for the 2021 women in STEM2D Scholar Awards
Jun 09, 2021: Johnson & Johnson releases 2020 health for humanity report highlighting performance and progress on Environmental, Social and Governance priorities
May 20, 2021: Johnson & Johnson Medical Korea and Johnson & Johnson Innovation announce launch of Seoul Innovation QuickFire Challenge on smart surgery in collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute
May 11, 2021: Kadant Johnson Promotes Jim Maggard to Lead Paper, Packaging and Tissue Sales
Apr 23, 2021: Collaboration with Johnson & Johnson Innovation to jump-start search for new malaria drugs
Apr 22, 2021: Covid-19 vaccine mixing: the good, the bad and the uncertain
Apr 20, 2021: Johnson & Johnson reports 2021 first-quarter results
Apr 12, 2021: EMA initiates review of J&J's Covid-19 vaccine over blood clot reports
Apr 12, 2021: Johnson & Johnson to Participate in the BofA Securities Virtual 2021 Healthcare Conference Johnson & Johnson to Participate in the BofA Securities Virtual 2021 Healthcare Conference
Mar 24, 2021: Johnson & Johnson announces five initiatives to help find the ‘missing Millions’ of Undiagnosed People Living With Tuberculosis

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Johnson & Johnson, Key Facts
Johnson & Johnson, Key Employees
Johnson & Johnson, Key Employee Biographies
Johnson & Johnson, Major Products and Services
Johnson & Johnson, History
Johnson & Johnson, Subsidiaries
Johnson & Johnson, Key Competitors
Johnson & Johnson, Ratios based on current share price
Johnson & Johnson, Annual Ratios
Johnson & Johnson, Annual Ratios (Cont...1)
Johnson & Johnson, Annual Ratios (Cont...2)
Johnson & Johnson, Interim Ratios
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Johnson & Johnson, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Johnson & Johnson, Performance Chart (2016 - 2020)
Johnson & Johnson, Ratio Charts
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


More Publications